Skip to main content
Genomtec S.A. (WSE:GMT)
Poland flag Poland · Delayed Price · Currency is PLN
5.00
+0.07 (1.32%)
At close: Mar 6, 2026

Genomtec Income Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.02000.040.220.02
Revenue Growth (YoY)
1400.00%--97.50%-81.73%995.00%-
Cost of Revenue
8.134.310.793.275.383.53
Gross Profit
-8.12-4.31-0.79-3.23-5.16-3.51
Selling, General & Admin
5.539.149.438.575.3610.97
Other Operating Expenses
-2.79-2.32-1.15-0.31-3.53-3.62
Operating Expenses
2.746.828.298.261.837.36
Operating Income
-10.86-11.13-9.08-11.49-7-10.86
Interest Expense
-0.15---0.2-0.03-0.02
Interest & Investment Income
0.01----0
Currency Exchange Gain (Loss)
-0---0.1-0.09-0.06
Other Non Operating Income (Expenses)
-0.08-0.080.07-0.09--0
Pretax Income
-11.08-11.21-9.01-11.88-7.11-10.94
Income Tax Expense
-0.07--0.050.010
Net Income
-11.01-11.21-9.01-11.93-7.12-10.94
Net Income to Common
-11.01-11.21-9.01-11.93-7.12-10.94
Shares Outstanding (Basic)
15-12988
Shares Outstanding (Diluted)
15-12988
Shares Change (YoY)
12.82%-30.90%14.78%--
EPS (Basic)
-0.73--0.74-1.27-0.87-1.34
EPS (Diluted)
-0.73--0.74-1.27-0.87-1.34
Free Cash Flow
---11.48-7.93-5.71-2.63
Free Cash Flow Per Share
---0.94-0.85-0.70-0.32
Operating Margin
-72400.00%-1113000.00%-907800.00%-28730.00%-3194.06%-54315.00%
Profit Margin
-73393.33%-1120800.00%-901300.00%-29820.00%-3248.86%-54695.00%
Free Cash Flow Margin
---1147900.00%-19822.50%-2608.68%-13135.00%
EBITDA
-8.16-8.83-7.92-11.06-6.49-10.62
D&A For EBITDA
2.72.31.160.440.50.24
EBIT
-10.86-11.13-9.08-11.49-7-10.86
Source: S&P Capital IQ. Standard template. Financial Sources.